insights_auto
Why is NZM2 up 4.09%?
Dive Deeperchevron_right
NZM2:ETR
Novozymes A/S
€58.00
arrow_upward
+4.09%(+2.28) 1D
Oct 5, 5:35:35 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NZM2...
Open
€56.28
High
€58.00
Low
€56.22
Mkt. cap
172.47B
Avg. vol.
136.00
Volume
182.00
52-wk high
€61.96
52-wk low
€46.74
No. of employees
11K
Open
€56.28
High
€58.00
Low
€56.22
Mkt. cap
172.47B
Avg. vol.
136.00
Volume
182.00
52-wk high
€61.96
52-wk low
€46.74
No. of employees
11K
News stories
From web sources and news partners
AD HOC NEWS
·
4 hours ago
Novonesis stock after-hours at EUR 57.07: plus 2.42 percent versus prior close
www.marketscreener.com
·
7 hours ago
Transactions under Novonesis’ share buyback program
Dairy Business Middle East & Africa
·
2 days ago
Novonesis strengthens dairy innovation with facility expansion
Profile
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, Greater Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
About Novozymes A/S